A User's Guide to the Inverted Terminal Repeats of Adeno-Associated Virus
- PMID: 31752513
- DOI: 10.1089/hgtb.2019.276
A User's Guide to the Inverted Terminal Repeats of Adeno-Associated Virus
Abstract
Ongoing development of recombinant vectors based on adeno-associated virus (rAAV) is providing an increasingly powerful and widely used toolkit for gene transfer and genome editing applications. While conceptually simple, the system harbors considerable complexity that presents many potential pitfalls for the inexperienced user. The short inverted terminal repeats (ITRs) can prove to be particularly problematic during vector engineering due to inherent instability necessitating diligent quality control measures during vector manufacture. This is especially important from a clinical standpoint when consistent purity and potency are paramount, and all components of the system are rigorously scrutinized by regulatory agencies. Despite the discovery over 30 years ago that the AAV ITRs are the only cis-acting elements of the virus required for vector production, there is a scarcity of reviews specifically focused on these complex elements. This review provides an overview of the ITR with the dual purpose of acting as a user's guide in the application of AAV vector technology and as a roadmap for ongoing vector development and optimization.
Keywords: AAV; ITR; adeno-associated virus; inverted terminal repeats; quality control.
Similar articles
-
Impact of Inverted Terminal Repeat Integrity on rAAV8 Production Using the Baculovirus/Sf9 Cells System.Hum Gene Ther Methods. 2017 Oct;28(5):277-289. doi: 10.1089/hgtb.2016.133. Hum Gene Ther Methods. 2017. PMID: 28967288 Free PMC article.
-
Adeno-Associated Virus Serotype-Specific Inverted Terminal Repeat Sequence Role in Vector Transgene Expression.Hum Gene Ther. 2020 Feb;31(3-4):151-162. doi: 10.1089/hum.2019.274. Hum Gene Ther. 2020. PMID: 31914802 Free PMC article.
-
Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences.Hum Gene Ther Methods. 2012 Feb;23(1):18-28. doi: 10.1089/hgtb.2011.034. Hum Gene Ther Methods. 2012. PMID: 22428977
-
Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids.Hum Gene Ther Methods. 2016 Feb;27(1):1-12. doi: 10.1089/hgtb.2015.140. Hum Gene Ther Methods. 2016. PMID: 26757051 Free PMC article. Review.
-
Chimeric herpes simplex virus/adeno-associated virus amplicon vectors.Curr Gene Ther. 2006 Jun;6(3):315-24. doi: 10.2174/156652306777592090. Curr Gene Ther. 2006. PMID: 16787183 Review.
Cited by
-
Predicted deleterious variants in the human genome relevant to gene therapy with adeno-associated virus vectors.Mol Ther Methods Clin Dev. 2023 Oct 13;31:101136. doi: 10.1016/j.omtm.2023.101136. eCollection 2023 Dec 14. Mol Ther Methods Clin Dev. 2023. PMID: 38089635 Free PMC article.
-
Rational engineering of a functional CpG-free ITR for AAV gene therapy.Gene Ther. 2022 Jun;29(6):333-345. doi: 10.1038/s41434-021-00296-0. Epub 2021 Oct 6. Gene Ther. 2022. PMID: 34611321 Free PMC article.
-
A robust and flexible baculovirus-insect cell system for AAV vector production with improved yield, capsid ratios and potency.Mol Ther Methods Clin Dev. 2024 Mar 4;32(2):101228. doi: 10.1016/j.omtm.2024.101228. eCollection 2024 Jun 13. Mol Ther Methods Clin Dev. 2024. PMID: 38524756 Free PMC article.
-
Riboswitch-controlled IL-12 gene therapy reduces hepatocellular cancer in mice.Front Immunol. 2024 Mar 15;15:1360063. doi: 10.3389/fimmu.2024.1360063. eCollection 2024. Front Immunol. 2024. PMID: 38558809 Free PMC article.
-
Targeted long-read sequencing captures CRISPR editing and AAV integration outcomes in brain.Mol Ther. 2023 Mar 1;31(3):760-773. doi: 10.1016/j.ymthe.2023.01.004. Epub 2023 Jan 6. Mol Ther. 2023. PMID: 36617193 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
